- Home
- RPRX vs MDB Comparison
RPRX vs MDB Comparison
Compare RPRX & MDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RPRX | MDB |
|---|---|---|
| Founded | 1996 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.2B | 15.8B |
| IPO Year | 2020 | 2017 |
Fundamental Metrics
Financial Performance| Metric | RPRX | MDB |
|---|---|---|
| Price | $39.70 | $408.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 38 |
| Target Price | $46.00 | ★ $413.21 |
| AVG Volume (30 Days) | ★ 4.3M | 2.2M |
| Earning Date | 11-05-2025 | 12-01-2025 |
| Dividend Yield | ★ 2.21% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.75 | N/A |
| Revenue | ★ $2,349,844,000.00 | $2,317,123,000.00 |
| Revenue This Year | $37.13 | $18.77 |
| Revenue Next Year | $1.48 | $17.04 |
| P/E Ratio | $22.68 | ★ N/A |
| Revenue Growth | 3.70 | ★ 20.93 |
| 52 Week Low | $24.05 | $140.78 |
| 52 Week High | $41.24 | $419.50 |
Technical Indicators
Market Signals| Indicator | RPRX | MDB |
|---|---|---|
| Relative Strength Index (RSI) | 57.50 | 70.74 |
| Support Level | $39.24 | $321.26 |
| Resistance Level | $40.50 | $419.50 |
| Average True Range (ATR) | 0.91 | 14.28 |
| MACD | -0.08 | 7.47 |
| Stochastic Oscillator | 76.02 | 90.64 |
Price Performance
Historical ComparisonAbout RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About MDB MongoDB Inc.
Founded in 2007, MongoDB is a vendor of a document-oriented database that accelerates development processes of new applications. Enterprise customers can choose between the fully managed offering, MongoDB Atlas, or the self-managed version, MongoDB Enterprise Advanced. MongoDB is a popular tool among developers, and its free Community Server has recorded over 500 million downloads since 2009.